GI Cancer

Proteomics: the next step in bowel cancer control

What genomics has done to advance a personalised medicine approach to bowel cancer is just the beginning; wait till we see what proteomics can do. This is the vision and message from Professor Mark Molloy, the inaugural Lawrence Penn Chair in Bowel Cancer Research at the University of Sydney. Professor Molloy told the limbic we ...

Already a member?

Login to keep reading.

© 2022 the limbic